Kang, J., Korecka, M., Toledo, J. B., Trojanowski, J. Q., & Shaw, L. M. (2013). Clinical Utility and Analytical Challenges in Measurement of Cerebrospinal Fluid Amyloid-β(1–42) and τ Proteins as Alzheimer Disease Biomarkers.
Styl ChicagoKang, Ju-Hee, Magdalena Korecka, Jon B. Toledo, John Q. Trojanowski, a Leslie M. Shaw. Clinical Utility and Analytical Challenges in Measurement of Cerebrospinal Fluid Amyloid-β(1–42) and τ Proteins As Alzheimer Disease Biomarkers. 2013.
Citace podle MLAKang, Ju-Hee, et al. Clinical Utility and Analytical Challenges in Measurement of Cerebrospinal Fluid Amyloid-β(1–42) and τ Proteins As Alzheimer Disease Biomarkers. 2013.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..